These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 19594623

  • 1. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
    Minami M, Ohmori D, Tatsuno I, Isaka M, Kawamura Y, Ohta M, Hasegawa T.
    FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
    [Abstract] [Full Text] [Related]

  • 2. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR.
    Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
    [Abstract] [Full Text] [Related]

  • 3. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?
    Walls T, Power D, Tagg J.
    J Med Microbiol; 2003 Sep; 52(Pt 9):829-833. PubMed ID: 12909662
    [Abstract] [Full Text] [Related]

  • 4. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
    Wescombe PA, Upton M, Dierksen KP, Ragland NL, Sivabalan S, Wirawan RE, Inglis MA, Moore CJ, Walker GV, Chilcott CN, Jenkinson HF, Tagg JR.
    Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
    [Abstract] [Full Text] [Related]

  • 5. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.
    Upton M, Tagg JR, Wescombe P, Jenkinson HF.
    J Bacteriol; 2001 Jul; 183(13):3931-8. PubMed ID: 11395456
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ.
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [Abstract] [Full Text] [Related]

  • 7. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
    Sawai J, Hasegawa T, Kamimura T, Okamoto A, Ohmori D, Nosaka N, Yamada K, Torii K, Ohta M.
    Antimicrob Agents Chemother; 2007 Feb; 51(2):461-7. PubMed ID: 17101685
    [Abstract] [Full Text] [Related]

  • 8. Inhibiting effects of Streptococcus salivarius on competence-stimulating peptide-dependent biofilm formation by Streptococcus mutans.
    Tamura S, Yonezawa H, Motegi M, Nakao R, Yoneda S, Watanabe H, Yamazaki T, Senpuku H.
    Oral Microbiol Immunol; 2009 Apr; 24(2):152-61. PubMed ID: 19239643
    [Abstract] [Full Text] [Related]

  • 9. The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.
    Dierksen KP, Moore CJ, Inglis M, Wescombe PA, Tagg JR.
    FEMS Microbiol Ecol; 2007 Mar; 59(3):584-91. PubMed ID: 17069620
    [Abstract] [Full Text] [Related]

  • 10. Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
    Tagg JR.
    Probiotics Antimicrob Proteins; 2009 Jun; 1(1):60-6. PubMed ID: 26783132
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a complement-binding protein, DRS, from strains of Streptococcus pyogenes containing the emm12 and emm55 genes.
    Binks M, Sriprakash KS.
    Infect Immun; 2004 Jul; 72(7):3981-6. PubMed ID: 15213143
    [Abstract] [Full Text] [Related]

  • 12. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
    Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, Chilcott CN, Reid G, Tagg JR.
    Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of bacteriocin-like inhibitory substances from dochi-isolated Enterococcus faecium D081821 and D081833.
    Chen YS, Yanagida F, Srionnual S.
    Lett Appl Microbiol; 2007 Mar; 44(3):320-5. PubMed ID: 17309511
    [Abstract] [Full Text] [Related]

  • 14. Purification of bacteriocin LS1 produced by human oral isolate Lactobacillus salivarius BGHO1.
    Busarcevic M, Kojic M, Dalgalarrondo M, Chobert JM, Haertlé T, Topisirovic L.
    Oral Microbiol Immunol; 2008 Jun; 23(3):254-8. PubMed ID: 18402613
    [Abstract] [Full Text] [Related]

  • 15. Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells.
    Hoe NP, Ireland RM, DeLeo FR, Gowen BB, Dorward DW, Voyich JM, Liu M, Burns EH, Culnan DM, Bretscher A, Musser JM.
    Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7646-51. PubMed ID: 12032337
    [Abstract] [Full Text] [Related]

  • 16. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
    Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR.
    J Appl Microbiol; 2006 Apr 28; 100(4):754-64. PubMed ID: 16553730
    [Abstract] [Full Text] [Related]

  • 17. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis.
    Tanaka M, Hasegawa T, Okamoto A, Torii K, Ohta M.
    Antimicrob Agents Chemother; 2005 Jan 28; 49(1):88-96. PubMed ID: 15616280
    [Abstract] [Full Text] [Related]

  • 18. Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.
    Wescombe PA, Heng NC, Burton JP, Tagg JR.
    Probiotics Antimicrob Proteins; 2010 Mar 28; 2(1):37-45. PubMed ID: 26780899
    [Abstract] [Full Text] [Related]

  • 19. Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A streptococcus caused by environmental changes.
    Nakamura T, Hasegawa T, Torii K, Hasegawa Y, Shimokata K, Ohta M.
    Arch Microbiol; 2004 Jan 28; 181(1):74-81. PubMed ID: 14673516
    [Abstract] [Full Text] [Related]

  • 20. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
    Pires R, Rolo D, Mato R, Feio de Almeida J, Johansson C, Henriques-Normark B, Morais A, Brito-Avô A, Gonçalo-Marques J, Santos-Sanches I.
    FEMS Microbiol Lett; 2009 Jun 28; 296(2):235-40. PubMed ID: 19486163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.